|

PAncreatic Disease Cohort of TOuLouse

RECRUITINGSponsored by University Hospital, Toulouse
Actively Recruiting
SponsorUniversity Hospital, Toulouse
Started2023-11-28
Est. completion2027-12
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT05824403

Summary

This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Patients with inflammatory or cystic exocrine pancreatic pathology
* Patient able to read and understand the information leaflet
* Patients who have agreed to participate in the study and have signed the free and informed consent
* Patients affiliated to a social security system (including AME)

Exclusion Criteria:

* Patient with pancreatic cancer pathology
* Patients with active cancer, whatever the origin
* Pregnant or breastfeeding patients
* Patients under legal protection, guardianship or trusteeship

Conditions2

CancerPancreatic Diseases

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.